Trulicity 0.75 mg

Trulicity 0.75 mg is a subcutaneous solution containing dulaglutide, used for managing type 2 diabetes. This medication supports blood sugar control as part of a comprehensive treatment plan.

Trulicity 0.75 mg is primarily used to improve glycemic control in adults with type 2 diabetes. It works by mimicking natural hormones in the body to lower blood sugar levels. This medication is often prescribed alongside diet and exercise to manage diabetes effectively.

Common effects of Trulicity 0.75 mg may include nausea, diarrhea, vomiting, abdominal pain, and decreased appetite. Some users also experience injections site reactions such as redness, swelling, or itching. These effects are generally mild and may diminish over time.

Trulicity 0.75 mg should be used with caution in individuals with a history of pancreatitis or severe gastrointestinal disease. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the solution properly to maintain its efficacy.

Trulicity 0.75 mg may interact with other medications, including insulin and sulfonylureas, potentially increasing the risk of low blood sugar. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.